Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

Investors focused on top-and-bottom-line performance—important as they are—do so at the risk of neglecting another crucial ...

Thermo Fisher Scientific Inc.’s TMO recent slew of product launches reflects its ongoing commitment to innovation. The company gains early insights into customer needs through its strong partnerships, ...

The "Cholesterol Testing Products and Services Market by Product, by Test Cholesterol Tests, by Application, by End-User, and ...

The healthcare industry is in a transformative period. At the center of this change are the medical device companies of Northern Kentucky.

Single-use technologies in biopharmaceuticals are disposable tools that improve efficiency, reduce contamination, and cut costs. They are becoming popular for producing medicines like vaccines and ...

Roche plans to release the system in the US to run tests including vitamin D and steroid assays under CLIA before it possibly receives US Food and Drug Administration clearance.

The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 ...

The global vaccine storage equipment market, valued at US$0.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$0.86 billion in 2024 and an impressive US$1.21 billion by ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

After revenue boomed for biopharma manufacturers during the COVID pandemic, sales have stagnated for several CDMO giants, ...